Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, December 05, 2014 11:54:37 AM
bullish
ascending triangle breakout
$ACAD recent news/filings
## source: finance.yahoo.com
Tue, 25 Nov 2014 14:33:19 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 25, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and ...
read full: http://www.noodls.com/view/E872137554C9AFDAF39927396C8B06CE58B82E95
*********************************************************
Tue, 25 Nov 2014 14:00:00 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervou
read full: http://finance.yahoo.com/news/acadia-pharmaceuticals-present-upcoming-investor-140000954.html
*********************************************************
Wed, 19 Nov 2014 21:09:23 GMT ~ ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
read full: http://biz.yahoo.com/e/141119/acad8-k.html
*********************************************************
Wed, 19 Nov 2014 18:04:21 GMT ~ ACADIA PHARMACEUTICALS INC Financials
read full: http://finance.yahoo.com/q/is?s=acad
*********************************************************
Thu, 13 Nov 2014 14:13:33 GMT ~ ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 13, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ...
read full: http://www.noodls.com/view/F21F300959865A3FD7B26B03DB1693C0EFE6D99B
*********************************************************
$ACAD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ACAD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ACAD/company-info
Ticker: $ACAD
OTC Market Place: Not Available
CIK code: 0001070494
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
Incorporated In: DE, USA
$ACAD share structure
## source: otcmarkets.com
Market Value: $3,039,003,338 a/o Dec 04, 2014
Shares Outstanding: 99,770,300 a/o Oct 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$ACAD extra dd links
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ACAD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ACAD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ACAD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/news - http://finance.yahoo.com/q/h?s=ACAD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ACAD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ACAD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ACAD
DTCC (dtcc.com): http://search2.dtcc.com/?q=ACADIA+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ACADIA+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ACADIA+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.acadia-pharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.acadia-pharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.acadia-pharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ACAD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001070494&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ACAD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ACAD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ACAD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ACAD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ACAD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ACAD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ACAD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ACAD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ACAD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ACAD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ACAD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ACAD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ACAD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ACAD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ACAD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ACAD
$ACAD DD Notes ~ http://www.ddnotesmaker.com/ACAD
Recent ACAD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 10:53:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 10:46:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/23/2024 09:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:34:29 PM
- Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals • Business Wire • 09/23/2024 08:15:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 08/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:46:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:43:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:40:42 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:39:26 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:37:56 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:35:57 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:33:27 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:31:27 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:29:57 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:27:51 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:25:57 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/20/2024 08:23:55 PM
- Ryan Reynolds Announces More to Parkinson’s® Campaign • Business Wire • 08/14/2024 12:04:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 10:05:04 PM
- Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference • Business Wire • 08/07/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:13:44 PM
- Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview • Business Wire • 08/06/2024 08:05:00 PM
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024 • Business Wire • 07/24/2024 08:05:00 PM
- Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med • Business Wire • 07/18/2024 01:04:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM